Medicare
New E/M codes poised to increase endocrine reimbursement, reduce paperwork
This issue of Endocrine Today introduces the Putting It into Practice column, coordinated by Jonathan D. Leffert, MD, FACP, FACE, ECNU. In the coming months, Leffert and Endocrine Today will speak with experts to discuss best advice and strategies for a healthy endocrine practice.
Endocrine Society outlines policy options to expand insulin access
The Endocrine Society is advocating for a suite of policy changes to expand access to insulin, including government negotiation of drug prices, limiting price increases and eliminating rebates, according to a new position statement.
AOA rallies against Medicare payment cuts during COVID-19
Senate passes bill providing lifetime kidney transplant drug coverage to all recipients
The U.S. Senate voted in favor of legislation that extends Medicare coverage of immunosuppressants to all kidney transplant recipients, regardless of age, and ensures these medications are covered for life.
ACR warns CMS against 'most-favored nation' pricing model for Medicare Part B drugs
The American College of Rheumatology has urged CMS to reconsider its recent interim final rule that would establish a “most-favored nation” payment model for Medicare Part B drugs, arguing it would disrupt patient access to rheumatic care.
ACR commends reimbursement boost for cognitive care in 2021 Medicare Fee Schedule
The American College of Rheumatology has praised CMS for approving “long awaited” updates to cognitive care reimbursements for Medicare, increasing the amount for evaluation and management services.
Final CMS rule lowers Medicare payments to emergency physicians
The American College of Emergency Physicians announced that it is “disappointed and dismayed” by CMS’s final 2021 Medicare physician fee schedule rule, which will lead to reduced reimbursement for emergency medicine services.
CMS finalizes policy changes to inpatient-only, ASC-covered procedure lists
No decrease in Medicare spending after Look AHEAD lifestyle intervention
Among participants in the Look AHEAD trial of an intensive lifestyle intervention for weight loss, there was no difference in total Medicare spending between the intervention and control group over a 4-year period, according to study data.
Report: Medicare would save $400 million with transplant drug coverage
A recent analysis by the Congressional Budget Office estimates Medicare could save $400 million in the course of 10 years if lifetime immunosuppressive drug coverage were offered to Medicare patients with a kidney transplant.